A tiny Wall Street firm advising Pfizer on its giant deal has had an incredible year
REUTERS/Danny Moloshok
The 16-year-old firm has been an adviser on five massive transactions in what has been one of the busiest years for mergers and acquisitions on record.
Its biggest deal yet, Pfizer's $160 billion deal with Allergan, was announced Monday.
Guggenheim Securities is one of three boutiques advising Pfizer on the inversion deal.
The others are Moelis & Company and Centerview Partners. Goldman Sachs is also advising Pfizer on the deal.
As the investment bank has expanded further into sectors that Wall Street's biggest banks count on for M&A revenue, it has also taken key talent from top advisers elsewhere in the investment-banking business.
This includes Fares Noujaim, who was a star banker under Guggenheim executive chairman Alan Schwartz when they both worked at Bear Stearns, as well as healthcare-sector veterans from JPMorgan and Bank of America Merrill Lynch: Jeff Hoffman and Joseph Kohls.
Here is a breakdown of the 10 biggest deals for the bank, as tracked by the M&A data provider Dealogic - many of them, from the past 12 months - that have increased Guggenheim's clout in the banking world.
- A centenarian who starts her day with gentle exercise and loves walks shares 5 longevity tips, including staying single
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Having an regional accent can be bad for your interviews, especially an Indian one: study
- Dirty laundry? Major clothing companies like Zara and H&M under scrutiny for allegedly fuelling deforestation in Brazil
- 5 Best places to visit near Darjeeling
- Climate change could become main driver of biodiversity decline by mid-century: Study
- RBI initiates transition plan: Small finance banks to ascend to universal banking status
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market